Articles related to Reproductive Endocrinology

A 14-year international consensus effort involving 56 professional and patient organizations has renamed polycystic ovary syndrome to polyendocrine metabolic ovarian syndrome, a shift designed to better reflect the condition’s systemic hormonal and metabolic pathophysiology.

An international consensus involving more than 14,000 patients and health professionals renamed polycystic ovary syndrome to polyendocrine metabolic ovarian syndrome (PMOS) to reflect its endocrine and metabolic features.

The periconceptional period is critical for the probability of conception, pregnancy outcomes, and long-term offspring health, and maternal dietary patterns during this period may influence fertility as well as early embryonic development.

“If I can put smarter MRI adjacent to a robotic consult and seamlessly transfer from one image to the next, it allows me to have a very efficient, safe surgery, and ensure that I’ve removed all fibroids.” – Dr. Tamatha Fenster, New York-Presbyterian

Referral rates for newly diagnosed gynecological malignancy occurred in only 14.6% of eligible patients despite attendance rates of 81.7% when referrals were made.

For clinicians and patients alike, the message from this large registry-based analysis is clear: early pregnancy loss, whether induced or spontaneous, does not confer an elevated risk of subsequent breast cancer.